Last reviewed · How we verify
NCT03638349: ASCEND
Actions & Insights Evaluating a Novel Diabetes Management Solution
trial in Diabetes Mellitus ( Type 1 and Type 2) in 163 participants. Completed in 10 August 2018.
10 August 2018
Quick facts
| Lead sponsor | LifeScan Scotland Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 163 |
| Start date | 17 July 2018 |
| Primary completion | 10 August 2018 |
| Estimated completion | 10 August 2018 |
| Sites | 3 locations across United Kingdom |
Conditions studied
- Diabetes Mellitus ( Type 1 and Type 2) — all drugs for Diabetes Mellitus ( Type 1 and Type 2) →
Sponsor
LifeScan Scotland Ltd
Who can join
16 and older, any sex, with Diabetes Mellitus ( Type 1 and Type 2). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single visit outcome study to obtain qualitative and quantitative data for a new BGMS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03638349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other LifeScan Scotland Ltd trials
Trials by the same sponsor.
- NCT06052371 — Project VerioVue Enhancements - Neonate Study · terminated
- NCT06121856 — Project VerioVue Enhancements - Arterial Study · completed
- NCT04262700 — Customer Outcomes & Value Experiencing A New Monitoring Technology · NA · unknown
- NCT03851549 — A User Performance and System Use Evaluation of a New Blood Glucose Monitoring System ( BGMS) · NA · unknown
- NCT03920085 — Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03638349 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LifeScan Scotland Ltd
- Last refreshed: 10 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03638349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing